This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (20)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Acute Renal Failure  • Immunology, Other  • Transplantation  • Kidney Transplantation  • Review  • Alert me on articles by topic

Colm C. Magee, MD; Manuel Pascual, MD

Arch Intern Med. 2004;164:1373-1388.

Renal transplantation is the treatment of choice for most patients with end-stage renal disease. The shortage of donor organs, however, remains a major obstacle to successful, early transplantation. This shortage has actually worsened despite an increase in living family-related and unrelated donors. On the other hand, over the last 10 years, allograft and recipient survival have significantly improved. This encouraging outcome reflects many factors, particularly a favorable shift in the balance between the efficacy and toxicity of immunosuppressive regimens. As acute rejection and early graft loss have become less common, the focus is increasingly directed toward the prevention and treatment of the long-term complications of renal transplantation. These include suboptimal allograft function, premature death, cardiovascular disease, and bone disease. Thus, a multidisciplinary approach—rather than management of immunological issues alone—is now required to optimize long-term outcomes of renal transplant recipients.

From the Renal Division, Brigham and Women's Hospital (Dr Magee) and the Renal Division, Massachusetts General Hospital, Boston (Dr Pascual). Dr Pascual is now with the Transplantation Center of the Centre Hospitalier Universitaire Vaudois and the School of Biology and Medicine of Lausanne, Lausanne, Switzerland. The authors have no relevant financial interest in this article.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reimbursement and economic factors influencing dialysis modality choice around the world
Just et al.
Nephrol Dial Transplant 2008;0:gfm939v5-gfm939.
ABSTRACT | FULL TEXT  

Australian nephrologists' attitudes towards living kidney donation
Cunningham et al.
Nephrol Dial Transplant 2006;21:1178-1183.
ABSTRACT | FULL TEXT  

Pre-transplant plasma and cellular levels of CD44 correlate with acute renal allograft rejection
Rouschop et al.
Nephrol Dial Transplant 2005;20:2248-2254.
ABSTRACT | FULL TEXT  

Improvement of heart failure after renal transplantation: The complex maze of cardio-renal interaction
Ventura and Mehra
J Am Coll Cardiol 2005;45:1061-1063.
FULL TEXT